Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tarantula Venom Peptide Shows Promise as a Drug

15.07.2004


A tarantula venom peptide, GsMTx4, known to affect many organs, can be manipulated to withstand destruction in the stomach, making it a promising candidate for drugs that could treat cardiac arrhythmias, muscular dystrophy and many other conditions, University at Buffalo biophysicists have shown.



Moreover, the peptide, which is amphiphilic -- meaning fat-soluble on one side and water-soluble on the other, much like a detergent -- affects mechanically sensitive ion channels in membranes in a manner totally different than the standard "lock-and-key" binding mechanism.

Results of the research appear in the July 8 issue of the journal Nature.


The peptide is the only agent known to specifically block stretch-sensitive channels. Unlike other membrane channels that are sensitive to electrical potential or the binding of hormones and neurotransmitters, stretch-sensitive channels are activated by changes in membrane tension.

"Stretch-sensitive channels can play a key role in many normal tissue functions," said Tom Suchyna, Ph.D., research associate in the UB Center for Single Molecule Studies and first author on the paper. "These channels are involved in hollow-organ filling such as the bladder, in heart and circulatory-system responses to changes in blood pressure, proprioception -- knowing where your limbs and head are in space and time -- and fluid balance.

"They also are involved in abnormal tissue functions such as cardiac arrhythmias, congestive heart failure, elevated calcium levels in muscular dystrophy, and angiogenesis-supported tumor growth."

Earlier research by the UB group had shown that the novel peptide inhibits stretch-sensitive channels, but the researchers didn’t know how. To gain more information on the peptide’s possible receptor, Phillip Gottlieb, Ph.D., a co-investigator from the UB Department of Physiology and Biophysics and the Hughes Center for Single Molecule Studies, created a mirror image of the molecule, referred to as "right-handed," to observe the peptide-membrane interaction.

Since almost all proteins in nature on "left-handed," right-handed proteins won’t fit into a left-handed receptor, even if they have the same amino acid sequence. "It’s like putting your right foot into your left shoe," said Suchyna.

In this case, however, they found that both proteins inhibited stretch-sensitive channels. "If the right handed GsMTx4 works as well as the left-handed, it must be interacting with the stretch-activated channel by changing the tension that the channel senses in the membrane, rather than locking onto the channel," he said. "This leads us to believe that there is something unique about the membrane that surrounds stretch-sensitive channels, and that this special membrane environment attracts GsMTx4. That would explain why this peptide blocks only this type of channel."

In addition to providing valuable information on how the peptide works, the finding that both versions blocked the channels makes the peptide an attractive drug candidate. "This was an awesome tool to find," said Fred Sachs, Ph.D., UB professor of biophysics in the Hughes Center for Single Molecule Studies and senior author on the study.

"Peptides usually don’t make good drug candidates. They can’t be given by mouth because the stomach enzymes digest them, and they can cause an immune response. But because this peptide works in its right-handed form, and the normal left-handed digestive enzymes and left-handed antibodies don’t recognize it, oral administration is a definite possibility. It may be more than a lead compound for drug development. It may work just as it is.

"If this prognosis proves correct," said Sachs, "the peptide could be an effective treatment for atrial fibrillation, incontinence, muscular dystrophy, high blood pressure and other conditions governed by stress-sensitive channels."

Suchyna said the next steps will be to investigate the environment surrounding the channels, to study the role of stretch-activated channels in cardiac arrhythmias and to mutate the peptide to make it specific for different tissues.

Studies of these peptides on a model ion channel called gramicidin, reconstituted in artificial lipid membranes, were carried out by Sonya E. Tape, a graduate student, and Olaf S. Anderson, M.D., both from the Weill Medical College of Cornell University, and Roger E. Koeppe II, Ph.D., from the University of Arkansas.

The research was supported by grants from the National Institutes of Health.

The University at Buffalo is a premier research-intensive public university, the largest and most comprehensive campus in the State University of New York. UB’s more than 27,000 students pursue their academic interests through more than 300 undergraduate, graduate and professional degree programs.

| newswise
Further information:
http://www.buffalo.edu

More articles from Life Sciences:

nachricht Overlooked molecular machine in cell nucleus may hold key to treating aggressive leukemia
23.04.2019 | Cincinnati Children's Hospital Medical Center

nachricht Bacteria use their enemy -- phage -- for 'self-recognition'
23.04.2019 | Chinese Academy of Sciences Headquarters

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum gas turns supersolid

Researchers led by Francesca Ferlaino from the University of Innsbruck and the Austrian Academy of Sciences report in Physical Review X on the observation of supersolid behavior in dipolar quantum gases of erbium and dysprosium. In the dysprosium gas these properties are unprecedentedly long-lived. This sets the stage for future investigations into the nature of this exotic phase of matter.

Supersolidity is a paradoxical state where the matter is both crystallized and superfluid. Predicted 50 years ago, such a counter-intuitive phase, featuring...

Im Focus: Explosion on Jupiter-sized star 10 times more powerful than ever seen on our sun

A stellar flare 10 times more powerful than anything seen on our sun has burst from an ultracool star almost the same size as Jupiter

  • Coolest and smallest star to produce a superflare found
  • Star is a tenth of the radius of our Sun
  • Researchers led by University of Warwick could only see...

Im Focus: Quantum simulation more stable than expected

A localization phenomenon boosts the accuracy of solving quantum many-body problems with quantum computers which are otherwise challenging for conventional computers. This brings such digital quantum simulation within reach on quantum devices available today.

Quantum computers promise to solve certain computational problems exponentially faster than any classical machine. “A particularly promising application is the...

Im Focus: Largest, fastest array of microscopic 'traffic cops' for optical communications

The technology could revolutionize how information travels through data centers and artificial intelligence networks

Engineers at the University of California, Berkeley have built a new photonic switch that can control the direction of light passing through optical fibers...

Im Focus: A long-distance relationship in femtoseconds

Physicists observe how electron-hole pairs drift apart at ultrafast speed, but still remain strongly bound.

Modern electronics relies on ultrafast charge motion on ever shorter length scales. Physicists from Regensburg and Gothenburg have now succeeded in resolving a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

Fraunhofer FHR at the IEEE Radar Conference 2019 in Boston, USA

09.04.2019 | Event News

 
Latest News

Marine Skin dives deeper for better monitoring

23.04.2019 | Information Technology

Geomagnetic jerks finally reproduced and explained

23.04.2019 | Earth Sciences

Overlooked molecular machine in cell nucleus may hold key to treating aggressive leukemia

23.04.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>